4th Quarter - Report

ARNOLD & PORTER KAYE SCHOLER LLP for FERRING PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues relating to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Prescription Drug Pricing Reduction Act (S. 2543).

Foreign entity interest: Ferring International Center S.A. (Ferring Global) supports the policy issue listed above.

LobbyistCovered position, as disclosed
KRISTINE BLACKWOOD —
CJ MAHLER —
PARI MODY —
EUGENIA PIERSON —
MICKAYLA STOGSDILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (116th), S. 2051 (116th), H.R. 2113 (116th), S. 2543 (116th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.